Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer
Cureus · 03.12.2023
DOI: 10.7759/cureus.49867 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 03.12.2023. Verfasst von Divya Shah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, USA.
- Rheumatology, University of Arizona College of Medicine - Phoenix, Phoenix, USA.
Zitieren
APA
Shah, D., & Young, K. (2023). Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer. Cureus. https://doi.org/10.7759/cureus.49867
Vancouver
Shah D, Young K. Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer. Cureus. 2023. doi:10.7759/cureus.49867
BibTeX
@article{Shah2023,
author = {Shah, Divya and Young, Kristen},
title = {Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.49867}
}
EUVIMED